Mohit Manrao: Discussing cancer innovation and biomarkers at the STAT Summit
Mohit Manrao, SVP and Head of US Oncology at AstraZeneca and President of the AstraZeneca Foundation, posted the following on LinkedIn:
“I had the recent opportunity to participate in the STAT Summit, where we delved into the exciting advancements and persistent challenges in cancer innovation. From the role of AI and biomarker testing to policy and regulatory barriers.
If you are interested in understanding more about biomarkers and why this is one of the most transformative advancements in healthcare today, please take a minute to listen to the below clip.
During my conversation with STAT’s Nicholas St. Fleur, I highlighted the tremendous strides we’ve made in cancer care over the last ten years. However, it’s crucial to keep that momentum going. At AstraZeneca, we’re committed to centering patients in everything we do. Let’s continue to transform cancer care, and together, we will make Ambition 2030 a reality.”
Mohit Manrao is the SVP and Head of US Oncology at AstraZeneca and President of the AstraZeneca Foundation, where he leads community grant programs. As Executive Sponsor of AstraZeneca’s US Health Equity Initiative, he focuses on reducing healthcare disparities. He also serves as a Board Member of the National Pharmaceutical Council.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023